Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

A woman with lupus developed rare skin growths that went away on their own.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Sodium valproate can worsen psoriasis-like skin conditions.

Recognizing lupus as a cause of severe gut issues is crucial for effective treatment.

Allopurinol may cause rare granulomatous microscopic colitis.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

Managing multiple autoimmune diseases in one patient is very challenging.

Hydroxychloroquine may help delay skin damage in lupus patients.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

New psoriasis treatments are effective but come with side effects and risks.

A fungal enzyme was used to make compounds more soluble, aiding drug discovery and crop protection.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

A(1-7) treatment reduces symptoms of lupus in mice.

A 29-year-old woman with symptoms of both lupus and rheumatoid arthritis improved with specific medications.

Certain medications, like trimethoprim, can cause aseptic meningitis, especially in people with autoimmune conditions.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Trimethoprim-sulfamethoxazole can cause aseptic meningitis, especially in people with certain health conditions.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.